Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The healthcare giant delivered another strong quarter.

5 Key Highlights From CVS Health's Q3 Earnings Update

Drugstore chain and health insurer CVS Health announced on Wednesday that it beat Wall Street's forecasts for both profits and its earnings in.

CVS Beats Earnings Estimates While Fighting Off a $45 Billion Crime Spree

CVS Health Corporation (CVS) CEO Karen Lynch on Q3 2021 Results - Earnings Call Transcript

Strength in all three operating segments drove CVS Health's (CVS) revenues in the third quarter of 2021.

CVS Health (CVS) Q3 Earnings Top Estimates, 2021 EPS View Up

WOONSOCKET, R.I., Nov. 3, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that select CVS Pharmacy locations will be offering a two-dose primary series of the Pfizer-BioNTech COVID-19 pediatric vaccine to children ages five to 11 years of age starting on Sunday, 11/7, upon receipt and confirmation of vaccine supply.

CVS Health Announces Availability of Pfizer-BioNTech COVID-19 Pediatric Vaccine to Children Ages Five to 11

CVS Health's revenue and profits jumped in the third quarter as millions of Americans came to its drugstores for vaccinations against Covid-19, boosting the company's 2021 outlook yet again.

Covid Vaccines Boosts CVS Health Profits, Sales And 2021 Outlook

CVS Health Corporation's (NYSE: CVS) Q3 sales increased 10% Y/Y to $73.79 billion, beating the consensus of $70.49 billion, helped by filling more prescriptions and giving more Covid-19 vaccines. Adjusted operating income increased 12.5% to $4.07 billion primarily due to the administration of COVID-19 vaccinations, diagnostic testing, and increased front store volume and growth in specialty pharmacy.

CVS Health Q3 Earnings Helped By COVID-19 Vaccinations; Raises FY21 Earnings Outlook

CVS Health beat expectations for fiscal third-quarter earnings, as it got a lift from prescription refills and Covid-19 vaccinations.

CVS Health earnings beat expectations, but shares drop

CVS Health Corp reported a 10% rise in quarterly sales on Wednesday, as a surge in Delta variant cases across the United States bolstered demand for tests and COVID-19 vaccinations.

CVS quarterly sales rise 10% on demand for COVID-19 tests, vaccines

WOONSOCKET, R.I., Nov. 3, 2021 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2021.

CVS Health Reports Strong Third Quarter Results

CVS Health Corp. CVS, +0.55% said Wednesday its third-quarter net income increased to $1.59 billion, or $1.20 a share, from $1.22 billion, or 93 cents a share in the year-ago period. Adjusted earnings rose to $1.97 a share from $1.66 a share.

CVS Health net income rises 30%

A slowdown in overall Covid-19 vaccination rate likely resulted in a decline in revenue contribution from Covid-19 vaccine administration.

What Will We See From CVS Health Stock Post Q3 Results?

CVS Health (CVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for CVS Health (CVS) This Earnings Season?

ARLINGTON, Va., Nov. 2, 2021 /PRNewswire/ -- Today, the American Diabetes Association® (ADA) and CVS Health (NYSE: CVS) established a new partnership to support families in helping to prevent and manage diabetes, as well as fund research on the devastating health disparities that fuel the diabetes epidemic.

$10 Million Commitment Made to The American Diabetes Association by CVS Health to Reach Five Million Patients and Transform Health Outcomes

CVS Health's (CVS) consumer-centric digital approach to administering vaccines across the nation is expected to have strongly contributed to its Q3 performance.

CVS Health (CVS) to Report Q3 Earnings: What's in the Cards?

The Federal Reserve releases its decision on interest rates and likely an update on inflation Wednesday.

Fed decision, jobs report, CVS Health earnings top week ahead

WOONSOCKET, R.I., Oct. 27, 2021 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE CVS), announced the launch of its designated Gene-based, Cellular, and Other Innovative Therapies™ (GCIT) network.

Aetna launches Gene-Based, Cellular and Other Innovative Therapies™ (GCIT) designated network

WOONSOCKET, R.I., Oct. 26, 2021 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced its 2022 Medicare Advantage Prescription Drug (MAPD) plans outpace the Medicare Advantage industry in the percentage of members in plans rated 4.5 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS).

More than 3 out of 4 Aetna Medicare Advantage members in 4.5 Star-rated plans or higher for 2022 -- the highest percentage among national health insurers [1]

WOONSOCKET, R.I., Oct. 22, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that, following authorization from the Centers for Disease Control and Prevention (CDC) based on guidance from the organization's Advisory Committee on Immunization Practices (ACIP), select CVS Pharmacy locations are now offering the Moderna COVID-19 booster shot to eligible populations beginning Friday, October 22, in addition to the previously authorized Pfizer-BioNTech COVID-19 booster.

CVS Health Announces Availability of Moderna Booster to Eligible Populations

WOONSOCKET, R.I., Oct. 19, 2021 /PRNewswire/ -- The Aetna Connected Plan with CVS Health™ (NYSE: CVS) is a first-of-its-kind plan offering that will deliver the unique CVS Health® (NYSE: CVS) and Aetna capabilities in the Chicago market to help members access care when and where they need it – and at a more affordable price than a traditional plan.

Reinventing health care: The Aetna Connected Plan with CVS Health™ is helping deliver cost-effective, accessible and easy health care.

I wrote about CVS Health Corporation in the past with a bull thesis, arguing it is a perfect setup for a long call play. This article switches the focus to the longer term to analyze the most important aspects to evaluate its profit sustainability: return on capital and cost of capital.

CVS Health Corporation: Bull Thesis Reinforced By Profit Sustainability

In the latest trading session, CVS Health (CVS) closed at $84.48, marking a -1.58% move from the previous day.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

Academy Sports and Outdoors

Diamondback Energy

First Citizens BancShares

Alphabet

Goldman Sachs

Walgreens

“If you're going to steal, steal from the best,” Woody Allen once said.

My Purloined Portfolio Aims to Steal From Managers I Respect

CVS Health has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $12.06B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 2.33% yield

CVS Health A Top 25 Dividend Giant With 2.33% Yield

Doximity

Humana

All three of these telehealth companies are already profitable and have solid financials.

News for CVS Health Stock (CVS)